Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clostridioides difficile Infection: Diagnosis and Treatment Challenges

Pathogens(2024)10.3390/pathogens13020118Source: DataRank Database

Clostridioides difficile Infection: Diagnosis and Treatment Challenges is a research paper published in Pathogens (2024). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 9.66)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

John T. Fallon ORCID,Rajat Madan ORCID,Md. Zahidul Alam,John Markantonis ORCID

Live enrichment

PubMed:38392856 PMC:PMC10891949 OpenAlex:https://openalex.org/W4391316689

National Institutes of Health (NIH)

Grant: R01A115845

National Institutes of Health (NIH)

Grant: I01BX004630

NIAID NIH HHS

Grant: R01 AI158451

National Institutes of Health

Grant: 1R01NS115845-01

Effects of global brain health on sensorimotor recovery after stroke

National Institutes of Health

Grant: 5I01BX004630-03

Role of a common leptin receptor polymorphism in regulating neutrophil heterogeneity after C. difficile infection

FWCI

9.66

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2076-0817/13/2/118/pdf?version=1706345705

publisherhttps://www.mdpi.com/2076-0817/13/2/118/pdf?version=1706345705

publisherhttps://www.mdpi.com/2076-0817/13/2/118/pdf

journalhttps://doi.org/10.3390/pathogens13020118

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38392856

Fields of Study

Clostridium difficile and Clostridium perfringens researchMicroscopic ColitisHelicobacter pylori-related gastroenterology studies0303 health sciences03 medical and health sciences

MeSH Terms

Anti-Bacterial AgentsClostridium InfectionsDiarrheaHumansClostridioides difficileDrug Resistance, Bacterial

Keywords

ClostridioidesAntibioticsAntibiotic resistanceIntensive care medicineMedicineDiarrheaC difficileClostridium difficileFlora (microbiology)Incidence (geometry)ClindamycinDrug resistanceMicrobiologyInternal medicineBiologyBacteriaHost ImmunityDrug-resistant PathogenNucleic Acid Amplification TestingEnzyme ImmunoassaysRecurrent C. Difficile InfectionClostridioides Difficile InfectionCell Cytotoxicity Neutralization Assayrecurrent <i>C. difficile</i> infection<i>Clostridioides difficile</i> infectionClostridioides difficileRReviewAnti-Bacterial AgentsDrug Resistance, BacterialClostridium InfectionsHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being